Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 09:10:37 GMT 2023
by
admin
on
Sat Dec 16 09:10:37 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG1 |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
2372V1TKXK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/15/1551
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
||
|
WHO-ATC |
B06AC05
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
397213
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000174876
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
2055641
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
DB14597
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
NCT04070326
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
Lanadelumab
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
C166535
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545189
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
m12083
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
5309
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
2372V1TKXK
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
2372V1TKXK
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
CD-54
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
2055640
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
ALTERNATIVE | |||
|
1426055-14-2
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
Lanadelumab
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY | |||
|
10265
Created by
admin on Sat Dec 16 09:10:37 GMT 2023 , Edited by admin on Sat Dec 16 09:10:37 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_149 | 1_205 |
1_225 | 3_213 |
1_231 | 2_231 |
1_234 | 2_234 |
1_266 | 1_326 |
1_372 | 1_430 |
2_22 | 2_96 |
2_149 | 2_205 |
2_225 | 4_213 |
2_266 | 2_326 |
2_372 | 2_430 |
3_23 | 3_88 |
3_133 | 3_193 |
4_23 | 4_88 |
4_133 | 4_193 |
Glycosylation Type | MAMMALIAN |
Glycosylation Link Type | Site |
---|---|
N | 1_302 |
N | 2_302 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|